Per patient total 4-week costs of patients experiencing hypoglycaemia and costs per event
| All (n=332) | T1DM (n=130) | T2DM (n=202) | |||||
| All (n=332) | All (n=130) | Patients with SH (n=13) | Patients with NSH (n=117) | All (n=202) | Patients with SH (n=30) | Patients with NSH (n=172) | |
| Per patient total 4-week costs | |||||||
| Costs within the healthcare sector (including informal care), mean costs (SD) (min–max) | €98 (€325) (€0–€2101) | €46 (€248) (€0–€2101) | €426 (€696) (€14–€2101) | €4 (€16) (€0–€153) | €131 (€363) (€0–€1654) | €863 (€512) (€42–€1654) | €4 (€12) (€0–€78) |
| Productivity costs, mean costs (SD) (min–max) | €47 (€412) (€0–€6577) | €117 (€652) (€0–€6577) | €975 (€1905) (€0–€6577) | €22 (€77) (€0–€638) | €3 (€36) (€0–€510) | €0 (€0) (€0–€0) | €3 (€39) (€0–€510) |
| Per patient total 4-week costs of patients experiencing hypoglycaemia, mean costs (SD) (min–max) | €145 (€613) (€0–€8678) | €163 (€870) (€0–€8678) | €1401 (€2497) (€14–€8678) | €26 (€81) (€0–€638) | €134 (€364) (€0–€1654) | €863 (€512) (€42–€1654) | €7 (€41) (€0–€525) |
| Costs per event | |||||||
| Study population total 4-week costs of patients experiencing hypoglycaemia | €48 140 | €21 190 | €18 213 | €3042 | €27 068 | €25 890 | €1204 |
| Number of events based on SAQ* | 1700 | 1129 | 22† | 981 | 571 | 51‡ | 473 |
| Total costs per event (based on SAQ) | €28 | €19 | €828 | €3 | €47 | €508 | €3 |
| Number of events based on patient diary§ | 1923 | 1339 | 33 | 1139 | 584 | 25 | 483 |
| Total costs per event (based on patient diary)¶ | €25 | €16 | €552 | €3 | €46 | €1036 | €2 |
*The number of events excludes nocturnal events in order to prevent double counting. The number of events in patients with at least one severe event excludes non-severe events.
†Two patients experienced three events requiring assistance from another person to administer carbohydrate and/or glucagon, and two patients had two of these events, which increases the total number of events in the population.
‡Six patients experienced more than one event requiring assistance from another person to administer carbohydrate and/or glucagon, with one patients having six of these events.
§Number of events in patients with SH and NSH are limited to the number of severe and non-severe events, respectively, as reported within these groups.
¶Please note that the SD could not be calculated because costs per event were calculated by dividing total population costs by the total number of events in the population, but is expected to be substantial.
NSH, non-severe hypoglycaemia; SH, severe hypoglycaemia; T1DM, type 1 diabetes; T2DM, type 2 diabetes.